Xu B - Search Results

1

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer.

Zhang Y, Chen H, Mo H, Hu X, Gao R, Zhao Y, Liu B, Niu L, Sun X, Yu X, Wang Y, Chang Q, Gong T, Guan X, Hu T, Qian T, Xu B, Ma F, Zhang Z, Liu Z. Zhang Y, et al. Among authors: xu b. Cancer Cell. 2021 Dec 13;39(12):1578-1593.e8. doi: 10.1016/j.ccell.2021.09.010. Epub 2021 Oct 14. Cancer Cell. 2021. PMID: 34653365 Free article.

2

Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib.

Ma F, Sun T, Shi Y, Yu D, Tan W, Yang M, Wu C, Chu D, Sun Y, Xu B, Lin D. Ma F, et al. Among authors: xu b. Lung Cancer. 2009 Oct;66(1):114-9. doi: 10.1016/j.lungcan.2008.12.025. Epub 2009 Feb 6. Lung Cancer. 2009. PMID: 19201048

3

[Goserelin plus anastrozole in the treatment of premenopausal patients with metastatic breast cancer].

Yao SY, Xu BH, Li Q, Zhang P, Wang JY, Yuan P, Ma F, Cai RG. Yao SY, et al. Zhonghua Yi Xue Za Zhi. 2010 Mar 2;90(8):526-8. Zhonghua Yi Xue Za Zhi. 2010. PMID: 20367963 Chinese.

4

[Clinicopathological characteristics and prognostic significance of young patients with triple-negative breast cancer].

Zhang P, Xu BH, Ma F, Li Q. Zhang P, et al. Zhonghua Zhong Liu Za Zhi. 2010 Feb;32(2):128-31. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20403244 Chinese.

5

Prospective study of vinorelbine and capecitabine combination therapy in Chinese patients with metastatic breast cancer pretreated with anthracyclines and taxanes.

Fan Y, Xu B, Yuan P, Wang J, Ma F, Li Q, Zhang P, Li Q, Cai R. Fan Y, et al. Among authors: xu b. Chemotherapy. 2010;56(4):340-7. doi: 10.1159/000320186. Epub 2010 Aug 18. Chemotherapy. 2010. PMID: 20720418 Clinical Trial.

6

[Relationship between P-glycoprotein function in peripheral blood cells and multidrug resistance in breast carcinoma].

Ma F, Liao YQ, Fan Y, Wang YH, Liang JM, Ma J, Xu BH. Ma F, et al. Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):529-32. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21029698 Chinese.

7

[Comparison of fluorescence in situ hybridization and immunohistochemistry assessment for Her-2 status in breast cancer and its relationship to clinicopathological characteristics].

Li HH, Ma F, Zeng X, Wang JY, Yuan P, Fan Y, Xu BH. Li HH, et al. Zhonghua Yi Xue Za Zhi. 2011 Jan 11;91(2):76-80. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21418986 Chinese.

8

Goserelin plus letrozole as first- or second-line hormonal treatment in premenopausal patients with advanced breast cancer.

Yao S, Xu B, Li Q, Zhang P, Yuan P, Wang J, Ma F, Fan Y. Yao S, et al. Among authors: xu b. Endocr J. 2011;58(6):509-16. doi: 10.1507/endocrj.k11e-020. Epub 2011 Apr 29. Endocr J. 2011. PMID: 21532215 Free article.

9

[Effect of rs2293347 Polymorphism in EGFR on the Clinical Efficacy of Gefitinib  in Patients with Non-small Cell Lung Cancer].

Ma F, Xu B, Lin D, Sun T, Shi Y. Ma F, et al. Among authors: xu b. Zhongguo Fei Ai Za Zhi. 2011 Aug;14(8):642-5. doi: 10.3779/j.issn.1009-3419.2011.08.02. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21859544 Free PMC article. Chinese.

10

[Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].

Zhang P, Xu BH, Ma F, Li Q, Yuan P, Wang JY, Zhang P. Zhang P, et al. Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):381-4. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21875471 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,594 results

Search Page

Filters